WHO

WHO recommends Pfzier’s antiviral combo for Covid-19 patients  

22 April 2022

The World Health Organisation (WHO) has strongly recommended a combination of antiviral drugs for patients at a high risk of hospital admission due to Covid-19.   The WHO is recommending Pfizer’s oral antiviral drug (a combination of nirmatrelvir and ritonavir tablets) for patients with non-severe covid-19 who are at highest risk of hospitalisation, such as unvaccinated, […]